Daily Stock List
Indoor Harvest Corp. (INQD)
CFN Media Group, Cannabis Financial Network News, SmallCapVoice, Fast Money Alerts, MassiveStockProfits, Orbit Stocks, OTPicks, Penny Stock General, Stock Shock and Awe, and PennyPickAlerts reported earlier on Indoor Harvest Corp. (INQD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Indoor Harvest Corp., by way of its brand name Indoor Harvest®, is a full service, state-of-the-art design-build engineering company for the vertical farming and indoor agriculture industry. The Company provides production platforms and complete custom designed build outs for greenhouse and Building Integrated Agriculture (BIA) grows, tailored to the exact needs of almost any plant crop. Its patent pending aeroponic fixtures are based upon a modular concept in which main components are interchangeable. Indoor Harvest has its headquarters in Houston, Texas.
The Company is developing its aeroponic and hydroponic systems for use by horticulture enthusiasts and commercial operators who look to use aeroponic and hydroponic vertical farming methods within a controlled indoor environment. Indoor Harvest’s method enables the use of a central plant, or physical plant for operations. As a result, this cuts labor and maintenance costs.
The Company also provides custom design build services and consulting to the vertical farming industry from shallow raft through nutrient film technology. Indoor Harvest addresses the limited availability of affordable, advanced agricultural systems for vertical indoor farming for middle market operations.
The design of its products is for the production of aeroponic leafy greens, micro-greens, fruiting plants, and herbs. Indoor Harvest’s products and systems can be adapted for an array of other uses. These include horticulture research, medicinal plant production, pharmaceutical plant production, plant cloning, as well as hardwood propagation.
The patent pending Indoor Harvest® Modular Aeroponic System is based around seven chief fixture components. These fixtures consist of an Aeroponic Growth Tray (AGT), Aeroponic Growth Lid (AGL), Aeroponic Spray Manifold (ASM), Aeroponic Pressure Manifold (APM), Nutrient Delivery System (NDS), Water Reclamation and Recirculation System, and Lift Station (LS). These individual fixtures are combined to create a variety of aeroponic system configurations. They enable modular system construction.
Indoor Harvest is the lead commercial partner and co-developer of The City of Pasadena’s Clara Initiative. This Community Located Agriculture Research Area (a.k.a., CLARA) will be home to a unique, industrial-sized program launched by the City of Pasadena to redevelop the northern footprint of the city.
Indoor Harvest and select retail partners (in cooperation with The National Build Health Awareness Initiative For Healthy Living) are creating a huge, fully-functional indoor farming facility, highlighting the latest technological and methodological innovations in building integrated agriculture.
This past January, Indoor Harvest announced an alliance with OneWorld Business Finance via its division US Energy Capital (OneWorld), to assist with financing for its customers and projects. This new relationship will permit OneWorld to expand their business offering in this new industry. Moreover, it will allow clients expanded options for financing.
Mr. John Choo, Indoor Harvest’s Chief Executive Officer, said, “After conducting a search for a company that combined the experience we were looking for with the flexibility our clients need, we chose OneWorld. A centrally planned indoor farm facility is a cost intensive project. This partnership gives the operators in the industry a strong option to reduce their initial costs and efficiently manage their cashflow while they focus on growing crops and revenue."
Indoor Harvest Corp. (INQD), closed Monday's trading session at $0.40, down 0.99%, on 5,834 volume with 11 trades. The average volume for the last 60 days is 58,882 and the stock's 52-week low/high is $0.17/$0.90.
Validian Corp. (VLDI)
Stock News Now, Damn Good Penny Picks, Penny Picks, PREPUMP STOCKS, Penny Stock Newsletter, Value Penny Stocks, Epic Stock Picks, Hot Stock Profits, StockMarketIntel, TopPennyStockMovers, Profit Sensation, Pumps and Dumps, PennyStocks24, and OTC Stock Review reported earlier on Validian Corp. (VLDI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Validian Corp. provides software products for public and private enterprises. Fundamentally, the Company is a foremost innovator in cyber-security technology. Validian develops and markets solutions to protect against the threats of today's digital world. Validian is first-to-market to provide secure storage, access, and transfer of digital information on wired, wireless, or mobile networks over the Internet. Validian is based in Ottawa, Ontario, and the Company lists on the OTC Markets’ OTCQB.
Validian provides solutions that can undergo customization to the client's business process to ensure end-to-end authenticity, integrity, and custody of high value digital assets. The Company’s mission is to deliver inventive information protection solutions that help government agencies, enterprises, and individuals in decreasing the impact of theft, disclosure, non-compliance, or malicious tampering with digital assets.
Validian’s technology enables the next generation of secure Cloud Computing, Cloud Storage, Distributed Computing and Web Application and WebPortal Access and Usage for desktop and laptop computers, servers, tablets, and Smartphones. Its products include Validian Protect, which embeds its technology into any application.
Validian has extended its core technology, ValidianProtect, since Q4 2016. As a result, it is now the first cyber security technology to cover and seamlessly protect the full life cycle of data with secure access, retrieval, transfer, receipt, storage, and usage of digital information on all devices, operating systems, and technology platforms.
ValidianProtect can be integrated into an application in a couple of weeks, in comparison to the 9 to 24 months to integrate standard Crypto Protocols, such as SSL/TLS, PKI and PGP. However, it first takes an additional 9 to 24 months to develop a quality, new application.
Validian redesigned its ValidianProtect technology to include a group of downloadable, re-usable, feature modules. These make it possible for a programmer to speedily and easily add any combination of a considerable number of pre-built, commonly used functions and first-to-market differentiating features to or from any application, therefore saving them many man-years of previously extra development time.
Validian Corp. (VLDI), closed Monday's trading session at $0.024, down 2.04%, on 957,947 volume with 27 trades. The average volume for the last 60 days is 371,807 and the stock's 52-week low/high is $0.0173/$0.06.
BioSolar, Inc. (BSRC)
BioSolar Newsletter, TopPennyStockMovers, HoleinOneStocks.net, Investor News Source, Stock Roach, StockHideout, and TheLightningPicks reported on BioSolar, Inc. (BSRC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
BioSolar, Inc. is developing a leading-edge technology to increase the storage capacity, lower the cost, and also extend the life of lithium-ion batteries. The Company initially concentrated its development effort on high capacity cathode materials since most of contemporary Li-ion batteries are "cathode limited." With the aim of creating BioSolar’s next generation super battery technology, the Company is now investigating high capacity anode materials. Listed on the OTC Markets Group’s OTCQB, BioSolar is based in Santa Clarita, California.
Through integrating BioSolar supercapacitors as the high power front-end to battery banks, with fewer battery banks than would normally be required, daytime solar energy can be quickly and cost-effectively stored for nighttime use at a substantially lower cost. The technology will enable solar energy systems users to reduce their dependence or go completely off the electric utility power grid.
BioSolar has its BioBackSheet®. The Company is the foremost commercial provider of bio-based solar panel backsheets. A backsheet is a required insulating film in all solar photovoltaic panels. Its main purpose is to protect the solar panel components, specifically the solar cells and wires. BioSolar’s BioBackSheet® is the only commercially available Underwriters Laboratory (UL) certified bio-based backsheet.
BioSolar is developing BioSolar supercapacitors. This is technology for reducing the cost of storing the energy of the sun. The Company co-owns the patent-application for this supercapacitor technology with the University of California at Santa Barbara (UCSB). BioSolar is now funding a sponsored research program to advance its development.
BioSolar announced earlier that it jointly filed a patent application with UCSB. This invention forms the foundation for its super battery technology. The inventors of the jointly owned patent application include Dr. Alan Heeger and Dr. David Vonlanthen of UCSB, and Dr. David Lee, BioSolar’s Chief Executive Officer, and Dr. Stanley Levy, the Company’s Chief Technology Officer and Vice President.
BioSolar management believes that use of its silicon-metal (Si-M) anode materials, presently under development, can help lessen the cost of lithium-ion batteries. The expectation is that BioSolar’s Si-M anode material will be significantly less expensive than that of the benchmark silicon-carbon anode material, which is the key cost issue usually associated with battery technology. The Company’s belief is that its strategy of pursuing anode material advancements to support next-generation lithium-ion batteries can play a vital role within the electric vehicle sector, and the broader energy storage technology industry.
BioSolar, Inc. (BSRC), closed Monday's trading session at $0.038, down 7.32%, on 155,600 volume with 9 trades. The average volume for the last 60 days is 99,446 and the stock's 52-week low/high is $0.011/$0.33.
CLS Holdings USA, Inc. (CLSH)
MoneyTV, Stock Commander, Equity Observer, Value Penny Stocks, eliteotc, SMS Penny Picks, Wall Street Beauties, WINNINGOTC, SmallCapAllStars, TryBestPennyStocks.biz, HotStockProfits, Beacon Equity Research, InvestorSoup, Penny Stock Craze, Penny Stocks Finder, Stock Preacher, SuperStockTips, Fortune Stock Alerts, Penny Stock Professor, PennyPickAlerts andTraders350 reported earlier on CLS Holdings USA, Inc. (CLSH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CLS Holdings USA, Inc. is a development stage diversified cannabis company. CLS stands for "Cannabis Life Sciences," in recognition of its patent pending proprietary method of extracting assorted cannabinoids from the marijuana plant and converting them into a higher quality and quantity of products. CLS Holdings USA specializes in the extraction and conversion of cannabinoids. The Company has its corporate office in Boulder, Colorado.
CLS Holdings USA’s mission is to be the industry leader in the extraction, conversion and marketing of cannabinoid oils, wax, edibles, and shatter through leveraging its proprietary extraction methods and conversion processes. Its business model includes licensing operations, processing revenue, processing facilities, sale of products, brand creation, and consulting services.
CLS Labs took its initial step toward commercializing its proprietary methods and processes through entering into an arrangement in Colorado on April 17, 2015. It entered into an arrangement by way of CLS Labs Colorado to, among other things, license its proprietary technology, methods and processes to PRH in exchange for a fee; and build a processing facility and lease such facility, including equipment, to PRH.
CLS will agree to build out a processing facility and then lease the facility and equipment to the client for what will typically be a 10-year term. The client will be required to enter into an agreement of equal length to license CLS’s proprietary technology, methods, and processes exclusively for use in the processing facility.
The Company’s plan is to monetize the extraction method and produce revenues through the licensing of its proprietary methods and processes to others, as in the Colorado Arrangement, the processing of cannabis for others, and the purchase of cannabis and the processing and sale of cannabis-related products.
CLS Holdings USA’s plan is to lease buildings at which to build processing facilities. The Company anticipates that it can complete each build out in roughly four to six months after any applicable licensing and permitting requirements have been met.
CLS Holdings USA’s intention is to enter into arrangements with cannabis growers - CLS will process their cannabis for a fee. Under such arrangements, growers will deliver cannabis plants to one of CLS’s facilities for processing.
CLS Holdings will subsequently apply its proprietary extraction and conversion technology to produce cannabinoid concentrates that may be delivered to the grower in bulk form or, for an additional fee, in individually-labeled retail-ready packages of oils, edibles, wax or shatter.
CLS Holdings USA, Inc. (CLSH), closed Monday's trading session at $0.0985, up 140.24%, on 20,050 volume with 6 trades. The average volume for the last 60 days is 70,534 and the stock's 52-week low/high is $0.0247/$1.83.
Creative Realities, Inc. (CREX)
We are reporting on Creative Realities, Inc. (CREX) today, here at the QualityStocks Daily Newsletter.
Creative Realities, Inc. is a foremost provider of digital marketing solutions. The Company helps retailers and brands employ the latest technologies to inspire shopper engagement in and around the Store. Creative Realities provides digital marketing technology solutions to retailers, brand marketers, venue-operators, enterprises, and non-profits and other organizations in the U.S. and worldwide. The Company’s shares trade on the OTC Markets Group’s OTCQB.
Creative Realities has created and delivered consumer/shopper experiences. The Company designs and installs high-end audio-visual networks. In addition, it is actively providing recurring SaaS (Software as a Service) and support services across varied categories.
These categories include Automotive, Apparel & Accessories, Banking, Baby/Children, Beauty, CPG, Department Stores, Digital Out-of-Home (DOOH), Electronics, Fashion, Fitness, Foodservice/QSR, Financial Services, Gaming, Luxury, Mass Merchants, Mobile Operators, and Pharmacy Retail.
Regarding Content Management products and delivery, Creative Realities designs, curates, traffics, and delivers any form of content through best in class CMS software solutions, tailored to the schedule requirements for a single or multi-site network. Since the Company’s inception, it has successfully installed greater than 100,000 retail and out of home experiences.
Concerning Customer Service, Creative Realities hosts, monitors, as well as provides technical support to thousands of innovative deployments daily. This is through its Network Operation Center and Technical Services Team. Pertaining to Engineering, the Company provides complete systems engineering from blueprints to on-site programming and continuing systems management.
Last week, Creative Realities announced plans to report its financial results for the year ended December 31, 2016 on Tuesday, March 28, 2017, after the market closes. A conference call with management to review the results is scheduled for Wednesday, March 29, 2017 at 9:00 am Eastern Time. The call will be hosted by Mr. Rick Mills, Chief Executive Officer (CEO), and Mr. John Walpuck, Chief Operating and Chief Financial Officer (COO and CFO).
Creative Realities, Inc. (CREX), closed Monday's trading session at $0.22, up 4.76%, on 75,552 volume with 13 trades. The average volume for the last 60 days is 42,669 and the stock's 52-week low/high is $0.101/$0.331.
InMed Pharmaceuticals, Inc. (IMLFF)
The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.334, up 13.99%, on 1,642,800 volume with 600 trades. The stock’s average daily volume over the past 60 days is 808,994, and its 52-week low/high is $0.05/$0.4261.
CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces that InMed Pharmaceuticals Inc. (CSE: IN) (OTCQB: IMLFF), a preclinical biotech company focused on the development of cannabinoid therapeutics, was recently featured on Forbes.com in an article titled "InMed Pharmaceuticals Is More Than Just Another Cannabis Drug Company" that discussed the company's innovative database that maps out various cannabinoid combinations and the various diseases that they can address.
Read the entire article here on Forbes:
InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.
Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”
After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.
The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.
INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.
InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.
The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.
Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.
Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer
InMed Pharmaceuticals, Inc. Company Blog
InMed Pharmaceuticals, Inc. News:
InMed Pharmaceuticals' Unique Approach Featured in Forbes -- CFN Media
InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media
NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use
One Step Vending Corp. (KOSK)
The QualityStocks Daily Newsletter would like to spotlight One Step Vending Corp. (KOSK). Today, One Step Vending Corp. closed trading at $0.02281, up 3.68%, on 996,071 volume with 99 trades. The stock’s average daily volume over the past 60 days is 1,080,411, and its 52-week low/high is $0.0026/$0.17.
One Step Vending Corp. recently finished installing four new micro markets within a major pharmaceutical corporationís facility in San Diego. These four micro markets will serve approximately 250 people as the new center is filled with employees over the coming months. Perhaps more importantly than the recurring revenue expected to be generated from the new micro markets is the opportunity for further reach to additional corporations in San Diego.
One Step Vending Corp. (KOSK) is focused on growing through acquisitions and cooperative agreements with companies that have potential and capabilities of achieving sustainable growth and rapidly capturing market share. The company provides financing and operational business support while also helping build key growth strategies. Key business sectors actively targeted include food and refreshment services, self-checkout systems and mobile vending machines.
Corporate Refreshment Services Micro Markets Inc., a subsidiary of One Step Vending, is a self-checkout retailer that offers a wide range of food and beverages. With more than 150,000 units supplied to customers in the last twelve months, the company is experiencing triple-digit growth. Regardless if a traditional vending machine or the high-tech micro market is chosen, the location's patrons enjoy gourmet market deliciousness and quick market convenience.
Mainly targeting the office environment, the micro markets offer a fresh market-grab and go-food concept that doesn't cost the business anything to host. Each micro market can be customized for any size or look and feature an easy-to-use touch screen interface so anyone can easily shop, scan and pay for their items. Once installed, employees benefit from a diverse menu that includes healthy snacks, real food, classic vending favorites and much more.
The team behind this concept has been committed to staying at the forefront of vending technology for 15 years. By replacing traditional vending machines with micro markets, they experienced up to five times greater revenue in large accounts. Today, the groundwork is laid with unique capabilities and proven execution strategies.
With Corporate Refreshment Services setting the example, One Step Vending's mission is to support thousands of businesses in the realization of their business goals by delivering experiences that enrich and nourish. Fostering a winning network of associates and partners and building mutually loyalty and trust is core to the company's growth strategy. Disclaimer
One Step Vending Corp. Company Blog
One Step Vending Corp. News:
One Step Vending Corp. Installs Four New Micro Markets at a San Diego Pharmaceutical Facility
One Step Vending Corp. Installs Micro Market at Cushman Wakefield
One Step Vending Corp. Seeks Savvy Corporate Partners and Micro Market Investors for Mutually Beneficial Sales Growth Opportunities
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.60, off by 3.74%, on 2,565 volume with 10 trades. The stock’s average daily volume over the past 60 days is 12,243, and its 52-week low/high is $1.04/$5.84.
eXp World Holdings Inc. the holding company for eXp Realty LLC, The Agent-Owned Cloud Brokerage®, today announced that management will attend the The MicroCap Conference in New York on Tuesday, April 4th, 2017. eXp World Holdings will host one-on-one meetings throughout the day and is scheduled to present as follows:
The MicroCap Conference
Date: Tuesday, April 4, 2017
Presentation Time: 9:30 a.m. ET
Location: JW Marriott Essex House New York (160 Central Park S, New York, NY 10019) - Track 4
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp World Holdings to Present at The MicroCap Conference on April 4th in New York
eXp Realty Reaches 3,000 Agent Milestone
eXp World Holdings to Present at Annual ROTH Conference
The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.42, off by 6.58%, on 68,088 volume with 94 trades. The stock’s average daily volume over the past 60 days is 202,981 and its 52-week low/high is $0.12/$2.75.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer
Alan Klitenic, Director of Investor Relations for ChineseInvestors.com, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with SmallCapVoice.com
Alan Klitenic, Director of Investor Relations for ChineseInvestors.com, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with SmallCapVoice.com
ChineseInvestors.com Launches XiBiDi Biotechnology to Reach China's 1.4 Billion Consumer Base
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.83, up 1.07%, on 4,700 volume with 21 trades. The stock’s average daily volume over the past 60 days is 7,843, and its 52-week low/high is $1.33/$4.35.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group to Present at the 29th Annual ROTH Conference, March 15, 2017
Monaker Group Appoints Robert Post to Board of Directors
Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing
Today's Top 3
Small Cap Firm
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- ChineseInvestors.com, Inc. (CIIX) Alan Klitenic, Director of Investor Relations for ChineseInvestors.com, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with SmallCapVoice.com
- Dominovas Energy Corp. (DNRG) Enters Formal Negotiations to Open in India and Indonesia
- eXp World Holdings, Inc. (EXPI) to Present at The MicroCap Conference on April 4th in New York
- GreenStone Healthcare Corp. (GRST) Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
- India Globalization Capital, Inc. (NYSE: IGC) Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders
- InMed Pharmaceuticals Inc. (IMLFF) Unique Approach Featured in Forbes -- CFN Media
- MGX Minerals Inc. (MGXMF) Acquires 110,000 Acres of Paradox Basin, Utah Oil and Gas Leases
- Monaker Group, Inc. (MKGI) to Present at the 29th Annual ROTH Conference, March 15, 2017
- National Waste Management Holdings, Inc. (NWMH) Expands Territory with Acquisition of Burts Refuse, LLC
- One Step Vending Corp. (KOSK) Installs Four New Micro Markets at a San Diego Pharmaceutical Facility
- ORHub, Inc. (ORHB) NetworkNewsWire Announces Publication of Discussion on the Value of IT & Big Data Analytics for the Health Care Industry
- ProBility Media Corp. (PBYA) Files 10Q, Reports Third Consecutive Quarter of Revenue Growth
- Players Network (OTCQB: PNTV) Featured on MoneyTV with Donald Baillargeon, 2/17
- Singlepoint, Inc. (SING) Executes on Cannabis Acquisition Strategy -- CFN Media
- Stealth Technologies, Inc. (STTH) Announces 5 New Products